NDC 80425-0255-01 - Methylprednisolone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0255
- Requested NDC
- 80425-0255-01
- Package NDCs from labels
- 80425-0255-1, 80425-0255-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methylprednisolone - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0255-1 | Methylprednisolone | 1 in 1 CARTON | TABLET | 1 | 3 | |
| 80425-0255-1 | Methylprednisolone | 21 in 1 BLISTER PACK | TABLET | 21 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0255 | METHYLPREDNISOLONE TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, 2 package rows | 20250102_f19f4304-bf37-da04-e053-2a95a90a4044.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0255-1 | EA - Each | 80425-0255 | d9089c54-8cf4-4810-bf31-0eadb4c52580 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylprednisolone | METHYLPREDNISOLONE | REMEDYREPACK INC. | d2a0e52c-f724-40e6-9d2a-5f1487c104b6 | 2026-08-31 | Warnings, Adverse reactions | 259966 762675 X4W7ZR7023 |
| MethylPREDNISolone | METHYLPREDNISOLONE | PD-Rx Pharmaceuticals, Inc. | a14c4f76-6dd5-4c84-b6e5-e5abf19ab559 | 2026-08-10 | Warnings, Adverse reactions | 259966 X4W7ZR7023 |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | HAWAII REPACK, INC. | d0d5fc54-69e1-4303-96be-3f97adec6074 | 2026-07-03 | Warnings, Adverse reactions | ANDA204072 259966 762675 X4W7ZR7023 |
| Methylprednisolone | METHYLPREDNISOLONE | American Health Packaging | 97256c7e-5694-4148-926f-594b9d5c34f4 | 2026-07-01 | Warnings, Adverse reactions | 259966 X4W7ZR7023 |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | Preferred Pharmaceuticals Inc. | e27ab941-adc6-47b6-b217-08d095a851fd | 2026-06-23 | Warnings, Adverse reactions | ANDA204072 259966 762675 X4W7ZR7023 |
| Methylprednisolone | METHYLPREDNISOLONE | Mylan Pharmaceuticals Inc. | 22dd75d6-f89a-44f7-8ca6-b64c4e9806dd | 2026-06-22 | Warnings, Adverse reactions | 259966 762675 X4W7ZR7023 |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | St. Mary's Medical Park Pharmacy | 235ca8cf-1576-0dfd-e063-6394a90a8b25 | 2026-06-04 | Warnings, Adverse reactions | ANDA204072 259966 762675 X4W7ZR7023 |
| methylprednisolone | METHYLPREDNISOLONE | BluePoint Laboratories | 7092df48-4904-4047-9916-e585417a216f | 2026-05-22 | Warnings, Adverse reactions | 259966 762675 X4W7ZR7023 |
| MethylPREDNISolone | METHYLPREDNISOLONE | Par Health USA, LLC | c84cf5e6-746d-41fb-b3d8-2c0b8ba989af | 2026-04-16 | Warnings, Adverse reactions | 259966 762675 X4W7ZR7023 |
| methylprednisolone | METHYLPREDNISOLONE | A-S Medication Solutions | 646bb826-8d5a-4b03-adfb-ed45daa86d44 | 2026-03-07 | Warnings, Adverse reactions | 259966 762675 X4W7ZR7023 |
| Methylprednisolone | METHYLPREDNISOLONE | NuCare Pharmaceuticals,Inc. | bdd233d9-333d-7389-e053-2a95a90a4b42 | 2026-02-20 | Warnings, Adverse reactions | 259966 X4W7ZR7023 |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | REMEDYREPACK INC. | 445e59a6-8886-48e7-8116-253a82144934 | 2026-02-13 | Warnings, Adverse reactions | ANDA204072 259966 762675 X4W7ZR7023 |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | Sportpharm LLC | fd9f28a0-fd86-4767-876c-8520fddeccd2 | 2026-02-06 | Warnings, Adverse reactions | ANDA204072 259966 X4W7ZR7023 |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | Tianjin Tianyao Pharmaceuticals Co., Ltd. | e09eefd2-f423-40cb-87b6-3ee97e7f831b | 2026-01-22 | Warnings, Adverse reactions | ANDA204072 259966 X4W7ZR7023 |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | PHOENIX RX LLC | 476ef50d-7e77-75f6-e063-6294a90a26e4 | 2026-01-02 | Warnings, Adverse reactions | ANDA204072 259966 762675 X4W7ZR7023 |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | Epic Pharma, LLC | b1908c2a-c596-4e2a-b2bd-0745d4fea31a | 2026-01-02 | Warnings, Adverse reactions | ANDA204072 42806-400 259966 762675 a7416892-37af-4d45-ab52-5e5700e6b3e5 b1908c2a-c596-4e2a-b2bd-0745d4fea31a X4W7ZR7023 |
| methylprednisolone | METHYLPREDNISOLONE | Major Pharmaceuticals | 3885151c-963e-4d22-b5b4-58968503ad8c | 2025-12-26 | Warnings, Adverse reactions | 259966 X4W7ZR7023 |
| Medrol | METHYLPREDNISOLONE | Pharmacia & Upjohn Company LLC | 39d5270b-d957-4821-93d6-501b7b9f02d4 | 2025-11-14 | Warnings, Adverse reactions | 259966 762675 X4W7ZR7023 |
| methylprednisolone | METHYLPREDNISOLONE | Zydus Pharmaceuticals USA Inc. | eaa9c932-c659-4ef6-bf5a-186545d87320 | 2025-11-10 | Warnings, Adverse reactions | 259966 762675 X4W7ZR7023 |
| METHYLPREDNISOLONE | METHYLPREDNISOLONE | Direct_Rx | 8c3f3f63-8a05-7a4a-e053-2995a90ad95a | 2025-01-20 | Warnings, Adverse reactions | ANDA204072 259966 762675 X4W7ZR7023 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.